Cristiana I.
- Country
- Italy
- Department
- Scienze Mediche e Chirurgiche
Research Overview
Data & Insights
Has run more than one trial at 0 of 24 partner sites.
Specializations
Metabolic Liver Disease
Focus on Non-Alcoholic Steatohepatitis and related fibrosis in patients with metabolic risk factors.
- Fibrosis regression
- Liver histology improvement
- Compensated cirrhosis management
Research integrates obesity, dyslipidemia, and type 2 diabetes contexts.
Renal and Proteinuric Disorders
Investigation of IgA Nephropathy and chronic kidney disease with high proteinuria.
- Proteinuria reduction strategies
- SGLT2 inhibitor combinations
- Corticosteroid-sparing approaches
Efforts extend to dialysis populations and renal outcomes in metabolic disease.
Cardiovascular and Pulmonary Vascular Conditions
Targeted studies in Heart Failure across preserved and reduced ejection fractions.
- Outcome reduction in cardiovascular death
- Management of atrial fibrillation stroke risk
- Pulmonary arterial hypertension therapies
Integration of hypertension, ischemic heart disease, and vascular inflammation pathways.
Chronic Respiratory Diseases
Clinical focus on Idiopathic Pulmonary Fibrosis and progressive fibrosing interstitial lung disease.
- Fibrosis progression attenuation
- Asthma exacerbation reduction
- Chronic obstructive pulmonary disease management
Research also encompasses severe eosinophilic asthma and related inflammatory phenotypes.
Oncology and Hematologic Malignancies
Active investigation of Metastatic Castration‑Resistant Prostate Cancer and advanced solid tumours.
- Prostate cancer radiographic progression
- Colorectal cancer first‑line strategies
- Acute leukemias and targeted therapies
Efforts include personalized approaches for pancreatic, biliary, and small‑cell lung cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
